NCT07322146
Trial of Reducing Inpatient Antibiotic Durations in Children
Enrolling by Invitation
PHASE4Ages 60–17InterventionalTreatmentUniversity of California, San FranciscoInvestigator-initiated
~1,200 participants
Updated 2026-04-29 on ClinicalTrials.gov
What's tested:Study Drug Placebo
At a glance
Recruiting sites
0 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
DOOR-RADAR composite outcome at day 15
Measured over Day 15 after antibiotic initiation
Conditions
Where it's being run
10 sites across 8 statesOhio2
Utah2
Alabama1
Colorado1
District of Columbia1
Pennsylvania1
Tennessee1
Washington1
Study leadership
- Sunitha V Kaiser, MD, MSc · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- DOOR-RADAR composite outcome at day 15Day 15 after antibiotic initiation
This is a composite, ordinal outcome captured through caregiver survey on day 15 after antibiotic initiation. This outcome includes 3 domains: clinical treatment failure, symptom and function recovery, and antibiotic-associated adverse effects. Each participant is assigned an ordinal outcome category (eight possible categories, each representing a unique combination of the three domains).